• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染后持续性肺部疾病患者的临床、影像学和病理学表现。

Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection.

机构信息

Dept of Thoracic Diseases, G.B. Morgagni Hospital/University of Bologna, Forlì, Italy

Dept of Pathology, University Vita-Salute, Milan and San Raffaele Scientific Institute, Milan, Italy.

出版信息

Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02411-2021. Print 2022 Oct.

DOI:10.1183/13993003.02411-2021
PMID:35301248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8932282/
Abstract

Some patients experience pulmonary sequelae after SARS-CoV-2 infection, ranging from self-limited abnormalities to major lung diseases. Morphological analysis of lung tissue may help our understanding of pathogenic mechanisms and help to provide consistent personalised management. The aim of this study was to ascertain morphological and immunomolecular features of lung tissue. Transbronchial lung cryobiopsy was carried out in patients with persistent symptoms and computed tomography suggestive of residual lung disease after recovery from SARS-CoV-2 infection. 164 patients were referred for suspected pulmonary sequelae after COVID-19; 10 patients with >5% parenchymal lung disease underwent lung biopsy. The histological pattern of lung disease was not homogeneous and three different case clusters could be identified, which was mirrored by their clinical and radiological features. Cluster 1 ("chronic fibrosing") was characterised by post-infection progression of pre-existing interstitial pneumonias. Cluster 2 ("acute/subacute injury") was characterised by different types and grades of lung injury, ranging from organising pneumonia and fibrosing nonspecific interstitial pneumonia to diffuse alveolar damage. Cluster 3 ("vascular changes") was characterised by diffuse vascular increase, dilatation and distortion (capillaries and venules) within otherwise normal parenchyma. Clusters 2 and 3 had immunophenotypical changes similar to those observed in early/mild COVID-19 pneumonias (abnormal expression of STAT3 in hyperplastic pneumocytes and PD-L1, IDO and STAT3 in endothelial cells). This is the first study correlating histological/immunohistochemical patterns with clinical and radiological pictures of patients with post-COVID lung disease. Different phenotypes with potentially different underlying pathogenic mechanisms have been identified.

摘要

一些患者在感染 SARS-CoV-2 后会出现肺部后遗症,从自限性异常到重大肺部疾病不等。对肺部组织进行形态学分析有助于我们了解发病机制,并有助于提供一致的个性化管理。本研究旨在确定肺部组织的形态学和免疫分子特征。对持续有症状且从 SARS-CoV-2 感染中康复后 CT 显示有残留肺部疾病的患者进行经支气管肺冷冻活检。有 164 名患者因疑似 COVID-19 后肺部后遗症而被转介;10 名肺部实质疾病>5%的患者接受了肺活检。肺部疾病的组织学模式并不均匀,可识别出三种不同的病例群,这与其临床和影像学特征相吻合。簇 1(“慢性纤维化”)的特征是感染后先前存在的间质性肺炎进展。簇 2(“急性/亚急性损伤”)的特征是不同类型和程度的肺损伤,从机化性肺炎和纤维化非特异性间质性肺炎到弥漫性肺泡损伤不等。簇 3(“血管变化”)的特征是弥漫性血管增加、扩张和变形(毛细血管和小静脉),而其他正常的实质不受影响。簇 2 和簇 3 具有与早期/轻度 COVID-19 肺炎观察到的免疫表型变化相似的特征(增生性肺泡细胞中 STAT3 异常表达,内皮细胞中 PD-L1、IDO 和 STAT3 异常表达)。这是第一项将组织学/免疫组织化学模式与 COVID-19 后肺部疾病患者的临床和影像学图片相关联的研究。已经确定了不同的表型,它们可能具有不同的潜在发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/3fd07e576656/ERJ-02411-2021.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/eebe1f8c1f0f/ERJ-02411-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/4233b0722c28/ERJ-02411-2021.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/fcf3bdc46fb1/ERJ-02411-2021.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/635e493cf272/ERJ-02411-2021.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/3fd07e576656/ERJ-02411-2021.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/eebe1f8c1f0f/ERJ-02411-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/4233b0722c28/ERJ-02411-2021.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/fcf3bdc46fb1/ERJ-02411-2021.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/635e493cf272/ERJ-02411-2021.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e8/8932282/3fd07e576656/ERJ-02411-2021.05.jpg

相似文献

1
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection.SARS-CoV-2 感染后持续性肺部疾病患者的临床、影像学和病理学表现。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02411-2021. Print 2022 Oct.
2
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.Covid-19 间质性肺炎:冷冻活检的组织学和免疫组织化学特征。
Respiration. 2021;100(6):488-498. doi: 10.1159/000514822. Epub 2021 Mar 16.
3
[Clinical and morphological features of lung injury long-term after SARS-CoV-2 recovery].[新型冠状病毒肺炎康复后长期肺损伤的临床及形态学特征]
Ter Arkh. 2024 Apr 16;96(3):218-227. doi: 10.26442/00403660.2024.03.202647.
4
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.上皮细胞和内皮细胞在新冠肺炎早期肺炎中的致病作用:同谋与共犯。
Mod Pathol. 2021 Aug;34(8):1444-1455. doi: 10.1038/s41379-021-00808-8. Epub 2021 Apr 21.
5
Pathological post-mortem findings in lungs infected with SARS-CoV-2.感染 SARS-CoV-2 的肺部的病理解剖发现。
J Pathol. 2021 Jan;253(1):31-40. doi: 10.1002/path.5549. Epub 2020 Nov 4.
6
Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.持续性 COVID-19 间质性肺病。皮质类固醇治疗的观察性研究。
Ann Am Thorac Soc. 2021 May;18(5):799-806. doi: 10.1513/AnnalsATS.202008-1002OC.
7
Vascular/epithelial changes as late sequelae after recovery from SARS-COV-2 infection: an in-vivo comparative study.新冠病毒感染康复后的晚期后遗症——血管/上皮变化:一项体内比较研究
Histopathology. 2023 Aug;83(2):229-241. doi: 10.1111/his.14930. Epub 2023 Apr 27.
8
Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients.急性 COVID-19 后综合征中的肺循环异常:79 例患者的双能 CT 血管造影结果。
Eur Radiol. 2023 Jul;33(7):4700-4712. doi: 10.1007/s00330-023-09618-9. Epub 2023 Apr 25.
9
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).严重 COVID-19 与结缔组织病相关间质性肺病(CTD-ILD)急性加重的临床、血清学和组织病理学比较。
Front Immunol. 2020 Oct 2;11:587517. doi: 10.3389/fimmu.2020.587517. eCollection 2020.
10
Persistence of post-COVID lung parenchymal abnormalities during the three-month follow-up.新冠后肺实质异常在随访三个月期间持续存在。
Adv Respir Med. 2021;89(5):477-483. doi: 10.5603/ARM.a2021.0090. Epub 2021 Oct 6.

引用本文的文献

1
New perspectives on the progression of pulmonary fibrosis: the cascade from aberrant microvascular endothelial cell activation to fibrosis.肺纤维化进展的新视角:从异常微血管内皮细胞激活到纤维化的级联反应。
Front Med (Lausanne). 2025 Aug 21;12:1639043. doi: 10.3389/fmed.2025.1639043. eCollection 2025.
2
Respiratory burden in post-acute COVID-19 sequelae: a longitudinal study of airway and systemic inflammation and clinical outcomes.新冠后急性后遗症中的呼吸负担:气道与全身炎症及临床结局的纵向研究
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.01331-2024. eCollection 2025 May.
3
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.

本文引用的文献

1
Persistent Pneumonic Consolidations due to Secondary Organizing Pneumonia in a Patient Recovering from COVID-19 Pneumonia: A Case Report and Literature Review.新冠病毒肺炎康复患者继发机化性肺炎导致的持续性肺实变:一例报告及文献综述
Infect Chemother. 2023 Mar;55(1):121-127. doi: 10.3947/ic.2022.0128. Epub 2023 Jan 9.
2
Awake prone positioning for COVID-19 acute respiratory failure: imaging and histological background.COVID-19急性呼吸衰竭的清醒俯卧位:影像学和组织学背景
Lancet Respir Med. 2022 Feb;10(2):e14. doi: 10.1016/S2213-2600(21)00554-3.
3
Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
新冠后肺部残留异常患者的呼吸道微生物群与健康个体相似,且与特发性肺纤维化不同。
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00826-2024. eCollection 2025 May.
4
Management of Severe SARS-CoV-2-Associated Organizing Pneumonia With Immunoglobulins.使用免疫球蛋白治疗严重的新型冠状病毒2型相关机化性肺炎
Cureus. 2025 Jan 8;17(1):e77120. doi: 10.7759/cureus.77120. eCollection 2025 Jan.
5
The role of vascularity and the fibrovascular interface in interstitial lung diseases.血管形成及纤维血管界面在间质性肺疾病中的作用。
Eur Respir Rev. 2025 Feb 5;34(175). doi: 10.1183/16000617.0080-2024. Print 2025 Jan.
6
Lung long distance: histopathological changes in lung tissue after COVID-19 pneumonia.肺部远距离:新型冠状病毒肺炎后肺组织的组织病理学变化
Croat Med J. 2024 Dec 30;65(6):501-509. doi: 10.3325/cmj.2024.65.501.
7
Overlapping Systemic Proteins in COVID-19 and Lung Fibrosis Associated with Tissue Remodeling and Inflammation.新冠病毒肺炎和与组织重塑及炎症相关的肺纤维化中的重叠系统性蛋白质
Biomedicines. 2024 Dec 19;12(12):2893. doi: 10.3390/biomedicines12122893.
8
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities.经支气管钳取活检用于诊断与 COVID-19 相关的弥漫性肺实质异常。
BMC Pulm Med. 2024 Dec 23;24(1):631. doi: 10.1186/s12890-024-03449-0.
9
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis.新型冠状病毒肺炎、新型冠状病毒肺炎后间质性肺疾病和特发性肺纤维化中的趋同和发散性免疫异常
Am J Physiol Cell Physiol. 2025 Jan 1;328(1):C199-C211. doi: 10.1152/ajpcell.00528.2024. Epub 2024 Nov 7.
10
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis.减轻线粒体功能障碍衍生的活性氧并减轻炎症:瑞香素在病毒性肺炎危机中的潜力。
Front Pharmacol. 2024 Oct 18;15:1477680. doi: 10.3389/fphar.2024.1477680. eCollection 2024.
氨基酸代谢在因严重 COVID-19 住院时发生显著改变:来自纵向靶向代谢组学分析的结果。
Microbiol Spectr. 2021 Dec 22;9(3):e0033821. doi: 10.1128/spectrum.00338-21. Epub 2021 Dec 8.
4
Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.吲哚胺 2,3-双加氧酶(IDO)-1 和 IDO-2 的活性与 COVID-19 的严重病程。
J Pathol. 2022 Mar;256(3):256-261. doi: 10.1002/path.5842. Epub 2022 Jan 10.
5
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.PD-1 阻断可逆转新冠后免疫异常,并刺激抗 SARS-CoV-2 免疫反应。
JCI Insight. 2021 Dec 22;6(24):e146701. doi: 10.1172/jci.insight.146701.
6
Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?纤维化性间质性肺疾病的疾病病理学:是否全都是普通型间质性肺炎?
Lancet. 2021 Oct 16;398(10309):1437-1449. doi: 10.1016/S0140-6736(21)01961-9. Epub 2021 Sep 6.
7
CT of Post-Acute Lung Complications of COVID-19.COVID-19 后肺部并发症的 CT 表现。
Radiology. 2021 Nov;301(2):E383-E395. doi: 10.1148/radiol.2021211396. Epub 2021 Aug 10.
8
Pulmonary Parenchymal Changes in COVID-19 Survivors.COVID-19 幸存者的肺实质变化。
Ann Thorac Surg. 2022 Jul;114(1):301-310. doi: 10.1016/j.athoracsur.2021.06.076. Epub 2021 Jul 31.
9
Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease.基底上皮干细胞跨越警报素检查点引发病毒性肺病。
J Clin Invest. 2021 Oct 1;131(19). doi: 10.1172/JCI149336.
10
Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.抗 PD-1 封锁对 SARS-CoV-2 感染的潜在保护作用。
Biomed Pharmacother. 2021 Oct;142:111957. doi: 10.1016/j.biopha.2021.111957. Epub 2021 Jul 28.